Activation of RHOA–VAV1 signaling in angioimmunoblastic T-cell lymphoma-Reference-Cited by-同舟云学术

Activation of RHOA–VAV1 signaling in angioimmunoblastic T-cell lymphoma

Published:2017-08-23 Issue:3 Volume:32 Page:694-702
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Fujisawa M,Sakata-Yanagimoto M,Nishizawa S,Komori D,Gershon P,Kiryu M,Tanzima S,Fukumoto K,Enami T,Muratani M^ORCID,Yoshida K,Ogawa S,Matsue K,Nakamura N,Takeuchi K^ORCID,Izutsu K,Fujimoto K,Teshima T^ORCID,Miyoshi H,Gaulard P,Ohshima K,Chiba S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2017273.pdf

Reference50 articles.

1. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127: 2375–2390.

2. de Leval L, Gisselbrecht C, Gaulard P . Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol 2010; 148: 673–689.

3. Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, Miyake Y et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet 2014; 46: 171–175.

4. Palomero T . Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet 2014; 46: 166–170.

5. Yoo HY, Sung MK, Lee SH, Kim S, Lee H, Park S et al. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat Genet 2014; 46: 371–375.

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Function of a complex of p‐Y42 RhoA GTPase and pyruvate kinase M2 in EGF signaling pathway in glioma cells;Journal of Neurochemistry;2024-08-25

2. Mutations in Ras homolog family member A in patients with peripheral T-cell lymphoma and implications for personalized medicine;Cancer Biology & Medicine;2024-08-09

3. Clonal Hematopoiesis and Bone Marrow Infiltration in Patients With Follicular Helper T-Cell Lymphoma of Angioimmunoblastic Type;Modern Pathology;2024-07

4. Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma;Journal of Hematology & Oncology;2024-06-01

5. Genomic and transcriptomic profiling of peripheral T cell lymphoma reveals distinct molecular and microenvironment subtypes;Cell Reports Medicine;2024-02